Skip to content
StockMarketAgent
Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

DUSE/27N0 stock hub

DUSE/27N0 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

DUSE/27N0is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
873.6K
Dusseldorf Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
DUSE/27N0
In the news

Latest news · DUSE/27N0

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROE-537.4
P25 n/aP50 n/aP75 n/a
ROIC-319.5
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All DUSE/27N0 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
101
Groups with data
10
Currency
EUR
Showing 101 of 101 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

13
MetricValue
Country
Germany
Country code
DE
Exchange
Dusseldorf Stock Exchange
Financial currency
EUR
First seen
2026-05-10
Industry
Pharmaceutical Preparations
Last refreshed
2026-05-10
Market cap
EUR 873,611
Price
EUR 0.36
Price currency
EUR
Sic
2834
Symbol
duse/27N0
Website
https://cannovum.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

3
MetricValue
Earnings Yield
-373.32%
P/B ratio
1.01x
P/S ratio
219.06x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

8
MetricValue
Gross margin
100%
Gross Profit
EUR 3,988
Gross Profit Growth
0%
Net Income
EUR -3.3M
Pretax Margin
-81,779.56%
ROA
-146.3
ROE
-537.4
ROIC
-319.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

2
MetricValue
Cagr1y
44.62%
Revenue Growth5 Y
17.01x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

8
MetricValue
Asset Turnover
EUR 0
Assets
EUR 1.3M
Current Assets
EUR 1.3M
Equity
EUR 867,536
Liabilities
EUR 425,617
Long Term Assets
EUR 15,851
Tangible Book Value
EUR 867,536
Tangible Book Value Per Share
EUR 0.38

Liquidity

Current-asset coverage and working-capital efficiency metrics.

2
MetricValue
Working Capital
EUR 1.3M
Working Capital Turnover
EUR 0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-355.63%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

28
MetricValue
1Y total return
44.58%
50-day SMA
0.64
All Time High
7.3
All Time High Change
-95.07%
All Time High Date
2024-02-23
All Time Low
0.16
All Time Low Change
127.85%
All Time Low Date
2025-03-05
ATR
0.1
Ch YTD
-23.89
High
0.36
High52
0.75
High52 Date
2025-08-15
High52ch
-52%
Low
0.36
Low52
0.33
Low52 Date
2025-09-25
Low52ch
9.42%
Ma50ch
-44.16%
RSI
42.28
RSI Monthly
36.43
RSI Weekly
35.1
Sharpe ratio
-0.02x
Sortino ratio
-0.01
Total Return
-355.63%
Tr YTD
-23.89
Tr1m
-18.18%
Tr3m
-23.4%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
EUR -3.1M
Operating margin
-77,789.2

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

34
MetricValue
Average Volume
1,599.55x
Bv Per Share
0.38
Ch1m
-18.18
Ch1y
44.58
Ch3m
-23.4
Ch6m
-5.01
Change
0%
Change From Open
0
Close
0
Earnings Date
2026-06-18
EBIT
EUR -3.1M
EPS
EUR -1.41
F Score
1
Fiscal Year End
December
Founded
2,018
Is Primary Listing
0
Last Earnings Date
2025-12-19
Last Report Date
2024-06-30
Last Split Date
2023-12-11
Last Split Type
Reverse
Ma150
1.94
Ma150ch
-81.4%
Ma20
0.38
Ma20ch
-4.26%
Next Earnings Date
2026-06-18
Open
0.36
Position In Range
0
Ppne
14,968
Ptbv Ratio
1.01
Relative Volume
0.01x
Revenue
3,988x
Tr6m
-5.01%
Volume
0
Z Score
-6.27
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does DUSE/27N0 pay a dividend?

Capital-return profile for this ticker.

Performance

DUSE/27N0 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+44.6%
S&P 500 1Y: n/a
3Y total return
n/a
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Technical

DUSE/27N0 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
42.3
Neutral momentum band
Price vs 200-day MA
n/a
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
-0.02
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About DUSE/27N0

Hub-level FAQ points readers to the deeper analysis pages.

What is the current duse/27N0 stock rating?

duse/27N0 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full duse/27N0 analysis?

The full report lives at /stocks/duse/27N0/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for duse/27N0?

The latest report frames duse/27N0 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the duse/27N0 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.